We think that the article by contains inaccurate and misleading information. The first important criticism is the title, which implies that longitudinal data on the clinical course of the disease are to be presented. This can only be measured by observation over a period of time, and no such data w
Relation between height and clinical course in Duchenne muscular dystrophy
✍ Scribed by Zatz, Mayana ;Rapaport, Debora ;Vainzof, Mariz ;Rocha, Jane M. L. ;de Cássia M. Pavanello, Rita ;Colletto, Gloria M. D. D. ;Peres, Clovis A. ;Optiz, John M. ;Reynolds, James F.
- Publisher
- John Wiley and Sons
- Year
- 1988
- Tongue
- English
- Weight
- 366 KB
- Volume
- 29
- Category
- Article
- ISSN
- 0148-7299
No coin nor oath required. For personal study only.
📜 SIMILAR VOLUMES
A double-blind controlled trial of penicillamine and vitamin E against placebo was conducted in 106 boys with Duchenne muscular dystrophy. Nine dropped out of the study after being randomized. Patients were evaluated using an established protocol that measures muscle strength, joint contractures, fu
## Abstract In 132 DMD muscle biopsies we investigated the presence of dystrophin‐positive fibers and the relationship of dystrophin immunohistochemical pattern to the clinical severity of the disease. Reverted fibers were detected in 37% of patients; their prevalence increased significantly in eac
## Abstract We studied the reliability of a series of endpoints in an evaluation of subjects with Duchenne muscular dystrophy (DMD). The endpoints included quantitative muscle tests (QMTs), timed function tests, forced vital capacity (FVC), and manual muscle tests (MMT). Thirty‐one ambulatory subje